Central Laboratories Applications & Studies

  1. Enhancing Clinical Trials By Linking Them To RWD 5/16/2023

    Learn how integrating participant trial data and real-world data into a standard EDC system can promote success in obtaining IRB approval.

  2. Emerging Biotech Saves Over $300K On Phase I Oncology Trial 4/24/2023

    Discover how one platform was able to provide operational efficiencies, data integrity, and savings, enabling the advancement of a clinical program during economic uncertainty.

  3. Using IRT Data To Automate And Optimize Clinical Supply 4/17/2023

    Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.

  4. How To Double High-Performing Site Count In A Priority Indication 3/13/2023

    A top 10 biopharmaceutical company wanted to expand its site list in a priority indication and better understand how existing sites in their database performed. Find out what happened next.

  5. BMS Adopts A New Clinical Data Architecture 2/6/2023

    Learn how Bristol Myers Squibb was able to optimize data review processes to streamline and improve access to clinical trial records.

  6. Optimizing Data Services For Digital Trials With A Clinical Data Cloud 2/6/2023

    Learn how internal processes and comprehensive clinical data services for digital trials can be improved through the utilization of data clouds.

  7. Digital/Hybrid Trials Deliver Greater ROI Than Traditional Trials 2/2/2023

    In this paper, Tufts CSDD outlines why and how modernized clinical trials can drive greater savings (up to $40,000,000 per study) than traditional trials.

  8. Trial Rescue: Site Selection And Prioritization 12/16/2022

    A large pharmaceutical company was looking to validate its list of 100+ US sites for a chronic auto-immune disease study. Leveraging medical claims data, a site-level analysis was conducted to identify relevant patients meeting the trial’s I/E criteria.

  9. Medicenna Gains Precedent-Setting FDA Approval 12/8/2022

    Learn how Medicenna was able to leverage Synthetic Control Arm (SCA) to bolster Phase 2 findings and gain FDA approval to design a hybrid external control arm for their Phase 3 registrational trial.

  10. Preparing A New Drug Application (NDA) With A CDISC Conversion 9/21/2022

    Regulatory submissions are the most critical milestones in clinical research programs. Learn how quality submissions can accelerate time to market, maximize research investments and bring the benefit of new treatments to patients sooner.